In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients’ T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.
HHS Proposes ‘Disincentive’ Penalties for Information-Blocking Providers
Some 500,000 clinicians and many hospitals could be subject to new payment reductions or “disincentives” for violating the federal information blocking rule, which prohibits healthcare
November 1, 2023